The insider selling is modest and likely routine—CFO exercised options and sold, CMO sold after a grant. No strong bearish signal. Monitor for any upcoming catalysts or earnings; the company's 92% bullish analyst consensus and strong historical returns suggest positive sentiment may persist.
Price Chart
Executive Summary
Two C-suite insiders at Fennec Pharmaceuticals (CFO and CMO) sold a combined $1.03M in open-market shares over a 5-day window, representing 0.24% of market cap. The sales are modest in size and accompanied by routine option exercises and non-cash grants, suggesting liquidity-driven diversification rather than a bearish signal.
Key Financial Metrics
Key Facts
- CFO Robert Andrade sold 75,000 shares at $11.78 for $883,500 on 2026-08-27
- CMO Pierre Sargis Sayad sold 12,000 shares at $12.18 for $146,160 on 2026-08-31
- Total open-market sales: $1.03M, or 0.24% of $421M market cap
- CFO also exercised 21,928 derivative shares at $5.10 on 2026-08-28, a non-cash event
- Multiple executives received non-cash stock grants on 2026-08-31
Financial Impact
Insider sales of $1.03M are modest relative to $421M market cap (0.24%)
Risk Factors
- If selling continues or escalates, it could signal waning insider confidence
- Option exercises and grants increase share count modestly over time
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-FENC-1788332585482 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | SC 13G/A | $10.27 | awaiting T+60 | — | $10.15 (−1.17%) |
Aug 31, 2026 8w ago | Insider Cluster | $12.03 | awaiting T+60 | — | $10.15 (−15.63%) |
Aug 31, 2026 8w ago | Insider Cluster | $12.03 | awaiting T+60 | — | $10.15 (−15.63%) |
Aug 11, 2026 10w ago | Press Release | $12.78 | awaiting T+60 | — | $10.15 (−20.58%) |
Jun 15, 2026 19w ago | Press Release | $9.19 $11.65 | ▲ +26.77% | ▲ +25.77% | $10.15 (+10.45%) |
May 22, 2026 22w ago | 8-K | $9.89 $11.87 | ▲ +20.02% | ▲ +17.30% | $10.15 (+2.63%) |
May 18, 2026 23w ago | 8-K | $9.76 $12.06 | ▲ +23.57% | ▲ +17.28% | $10.15 (+4.00%) |
May 14, 2026 23w ago | Press Release | $9.24 $10.94 | ▲ +18.40% | ▲ +14.81% | $10.15 (+9.85%) |
May 7, 2026 24w ago | Press Release | $6.90 $9.59 | ▲ +38.99% | ▲ +35.15% | $10.15 (+47.10%) |
Apr 28, 2026 25w ago | 8-K | $6.26 $9.99 | ▲ +59.58% | ▲ +55.47% | $10.15 (+62.14%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers